• 150 Citations
  • 7 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kelly C. Rogers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Pharmacists Medicine & Life Sciences
Percutaneous Coronary Intervention Medicine & Life Sciences
Anticoagulants Medicine & Life Sciences
Heparin Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Interprofessional Relations Medicine & Life Sciences
Personnel Staffing and Scheduling Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

7 Citations (Scopus)

A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA)

Rogers, K. & Finks, S., Jan 1 2019, In : American Journal of Medicine. 132, 1, p. 38-41 4 p.

Research output: Contribution to journalReview article

Anticoagulants
United States Food and Drug Administration
Factor Xa
Antithrombins
Warfarin

An Underappreciated and Prolonged Drug Interaction Leads to Ineffective Anticoagulation

Rogers, K., Neu, D. W., Jaeger, M. C., Shah, R. & Finks, S., Feb 1 2019, In : Southern Medical Journal. 112, 2, p. 125-129 5 p.

Research output: Contribution to journalArticle

Drug Interactions
Communication
Rifampin
Drug-Related Side Effects and Adverse Reactions
Outpatients
1 Citation (Scopus)

Nitrate allergy and desensitization in a patient with refractory angina

Kessler, S. G., Gillion, A. R., Pattanaik, D. & Rogers, K., Apr 1 2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 4, p. 1322-1323 2 p.

Research output: Contribution to journalArticle

Nitrates
Hypersensitivity
2 Citations (Scopus)
Percutaneous Coronary Intervention
Randomized Controlled Trials
Mortality
Heparin
Stents
4 Citations (Scopus)

Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant

Finks, S. & Rogers, K., May 1 2017, In : American Journal of Medicine. 130, 5, p. e195-e197

Research output: Contribution to journalEditorial

Anticoagulants
idarucizumab